ATE194838T1 - Hydrochinon-derivate und deren pharmazeutische verwendung - Google Patents

Hydrochinon-derivate und deren pharmazeutische verwendung

Info

Publication number
ATE194838T1
ATE194838T1 AT97250280T AT97250280T ATE194838T1 AT E194838 T1 ATE194838 T1 AT E194838T1 AT 97250280 T AT97250280 T AT 97250280T AT 97250280 T AT97250280 T AT 97250280T AT E194838 T1 ATE194838 T1 AT E194838T1
Authority
AT
Austria
Prior art keywords
group
hydrogen atom
alkyl group
oxo
alkyl
Prior art date
Application number
AT97250280T
Other languages
English (en)
Inventor
Yoshiaki Isobe
Yuso Goto
Masanori Tobe
Osamu Takahashi
Original Assignee
Japan Energy Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japan Energy Corp filed Critical Japan Energy Corp
Application granted granted Critical
Publication of ATE194838T1 publication Critical patent/ATE194838T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pulmonology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT97250280T 1996-09-19 1997-09-17 Hydrochinon-derivate und deren pharmazeutische verwendung ATE194838T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP24827296 1996-09-19

Publications (1)

Publication Number Publication Date
ATE194838T1 true ATE194838T1 (de) 2000-08-15

Family

ID=17175664

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97250280T ATE194838T1 (de) 1996-09-19 1997-09-17 Hydrochinon-derivate und deren pharmazeutische verwendung

Country Status (13)

Country Link
US (2) US5821247A (de)
EP (1) EP0831092B1 (de)
AT (1) ATE194838T1 (de)
AU (1) AU716992B2 (de)
CA (1) CA2216288C (de)
DE (1) DE69702580T2 (de)
DK (1) DK0831092T3 (de)
ES (1) ES2149548T3 (de)
GR (1) GR3034418T3 (de)
NO (1) NO313413B1 (de)
NZ (1) NZ328769A (de)
PT (1) PT831092E (de)
ZA (1) ZA978413B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003523958A (ja) * 1999-12-23 2003-08-12 ニトロメド インコーポレーテッド ニトロソ化およびニトロシル化されたシクロオキシゲナーゼ−2の阻害剤、組成物ならびに使用法
EP1541562A4 (de) * 2002-09-20 2006-11-15 Dainippon Sumitomo Pharma Co Neue uracilderivate und deren medizinische verwendung
PL2220030T3 (pl) 2007-11-06 2016-07-29 Bioelectron Tech Corp Pochodne 4-(p-chinonylo)-2-hydroksybutanamidu do leczenia chorób mitochondrialnych
HUE058877T2 (hu) 2014-12-16 2022-09-28 Ptc Therapeutics Inc (R)-2-hidroxi-2-metil-4-(2,4,5-trimetil-3,6-dioxociklohexa-1,4-dienil)butánamid polimorf és amorf alakjai
ES3033538T3 (en) * 2015-10-08 2025-08-05 Khondrion Ip B V Novel compounds for treating mitochondrial disease

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5661153A (en) * 1994-07-19 1997-08-26 Japan Energy Corporation 1-arylpyrimidine derivatives and pharmaceutical use thereof

Also Published As

Publication number Publication date
DK0831092T3 (da) 2000-10-16
EP0831092A3 (de) 1998-04-08
PT831092E (pt) 2000-10-31
US5877318A (en) 1999-03-02
NO313413B1 (no) 2002-09-30
CA2216288C (en) 2006-02-07
CA2216288A1 (en) 1998-03-19
EP0831092B1 (de) 2000-07-19
AU3760197A (en) 1998-03-26
GR3034418T3 (en) 2000-12-29
NO974313D0 (no) 1997-09-18
EP0831092A2 (de) 1998-03-25
ES2149548T3 (es) 2000-11-01
DE69702580T2 (de) 2001-03-08
ZA978413B (en) 1998-03-26
NO974313L (no) 1998-03-20
DE69702580D1 (de) 2000-08-24
AU716992B2 (en) 2000-03-16
US5821247A (en) 1998-10-13
NZ328769A (en) 1998-07-28

Similar Documents

Publication Publication Date Title
CA2234096A1 (en) 1-(1,2-disubstituted piperidinyl)-4-substituted piperazine derivatives
ATE271557T1 (de) Dc-89 derivat
EP0955293A4 (de) Neue harnstoffderivate
EP0758653A4 (de) Imidazolchinazolinderivate
CA2093798A1 (en) Pyridine and pyridine n-oxide derivatives of diaryl methyl piperidines or piperazines, and compositions and methods of use thereof
AU2001293233A1 (en) Aza heterocyclic derivatives and their therapeutic use
DK0784974T3 (da) Fremstilling af xanthinderivater i fast dispersion
ATE218345T1 (de) Arzneimittel gegen spinocerebellare degeneration
AP9801321A0 (en) 2-(4-aryl or heteroaryl-piperazin-1-ylmethyl)-h-indole derivatives.
EP0292576A4 (en) Anti-ulcerous agent containing chalcone derivative as effective ingredient and novel chalcone derivatives
DE69702580D1 (de) Hydrochinon-Derivate und deren pharmazeutische Verwendung
EP0801065A4 (de) 1,4-dihydropyridinverbindungen und sie enthaltende medizinische zusammensetzungen
DE69122812D1 (de) Glutathionderivat
ATE170851T1 (de) Guanidinothiazolederivate und ihre anwendung als h2-rezeptor-antagonisten
ATE219065T1 (de) Arylpiperidin- und arylpiperazin-derivate und sie enthaltende arzneimittel
FR2778404B1 (fr) Derives du dihydro ou tetrahydronaphtalene, et les compositions pharmaceutiques les renfermant
ATE285771T1 (de) Diaminotrifluoromethylpyrimidinderivate enthaltende antikrebs-zusammensetzung
ES2151442B1 (es) Nuevo derivado del bencenoetanol.
BG102429A (en) Derivatives of 5-naphthalen-1-yl-1,3-dioxan, their preparation and usage as therapeutical means
DK378087A (da) Tetracycliske indolderivater
EP1048649A4 (de) 5-arylpyrrol-derivate
EP0887351A4 (de) Dc 107-derivate
DE69528984D1 (de) Hemmung der leukotrienbiosynthese mittels harnstoffderivaten
ATE117682T1 (de) Substituierte benzothiazolinone, ihre herstellung und sie enthaltende pharmazeutische zusammenstellungen.
EA200000922A1 (ru) Производные аминоантрациклинона и их применение в лечении амилоидоза

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee